Weiss Multi Strategy Advisers LLC Paratek Pharmaceuticals, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.93 - $4.5 $128,920 - $198,000	-44,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$5.36 - $7.24 $123 - $166	-23 Reduced 0.05%	44,000 $236,000
Q3 2018 Nov 14, 2018	BUY	$9.05 - $10.95 $1,746 - $2,113	193 Added 0.44%	44,023 $427,000
Q2 2018 Aug 14, 2018	BUY	$10.2 - $13.9 $39,066 - $53,237	3,830 Added 9.58%	43,830 $447,000
Q1 2018 May 15, 2018	BUY	$12.65 - $18.85 $63,250 - $94,250	5,000 Added 14.29%	40,000 $520,000
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $661,500 - $987,000	35,000	35,000 $879,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.